Strides Pharma Science shares rise sharply on Thursday after the USFDA issued an Establishment Inspection Report (EIR) for its Bengaluru facility, concluding a recent cGMP inspection. The inspection ended with five observations, which the company addressed through corrective actions. The regulatory closure offers relief after the stock’s recent weakness.
Rs 23,000 crore outflows! Is the September FII rout indicating a worse end to 2026?
Foreign investors have resumed selling Indian equities in September, with FPI outflows crossing Rs 23,000 crore through September 19. Higher crude prices, elevated US bond